Vitamin D: genetic regulation of inflammation in autoimmune, metabolic and microbial models

The study of cytokine production and its genetic regulation in diseases of various pathogenesis in childhood, which include several mechanisms of inflammation - this is autoimmune against the background of celiac disease, type 1 diabetes and CAI, lymphoproliferative against the background of oncohematological diseases, microbial-inflammatory against the background of chronic pyelonephritis and cystic fibrosis and metabolic against the background of obesity and a decrease in bone mineral density is necessary to expand understanding of pathogenesis, predict variants of the clinical course of diseases (clinical phenotypes) and complications, as well as response to therapy. The literature review is devoted to the analysis and interpretation of data on the effect of vitamin D supply and its genetic regulation on the course of diseases, combined according to the leading pathogenetic mechanism of inflammation into autoimmune, microbial, and lymphoproliferative models.

children, vitamin D, 25(OH)D deficiency, autoimmune inflammation, microbial inflammation, lymphoproliferative inflammation, VDR

1. Kaminsky LW, Al-Sadi R and Ma TY. IL-1b and the Intestinal Epithelial Tight Junction Barrier. Front. Immunol. 2021;12:767456.doi: 10.3389/fimmu.2021.767456

2. Delbue D, Cardoso-Silva D, Branchi F, Itzlinger A, Letizia M, Siegmund B, Schumann M. Celiac Disease Monocytes Induce a Barrier Defect in Intestinal Epithelial Cells.Int J Mol Sci. 2019 Nov 9;20(22):5597. doi: 10.3390/ijms20225597.

3. Xiong H, Zhang HT, Xiao HW, Huang CL, Huang MZ. Serum Metabolomics Coupling With Clinical Laboratory Indicators Reveal Taxonomic Features of Leukemia. Front Pharmacol. 2022 May 26;13:794042. doi: 10.3389/fphar.2022.794042.

4. Jiménez-Morales S, Aranda-Uribe IS, Pérez-Amado CJ, Ramírez-Bello J, Hidalgo-Miranda A. Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia. Front Immunol. 2021 Nov 18;12:737340. doi: 10.3389/fimmu.2021.737340.

5. Kuzilková D, Bugarin C, Rejlova K, Schulz AR, Mei HE, Paganin M, Biffi A, Biondi A, Kalina T, Gaipa G. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells. Haematologica. 2022 Jun 1;107(6):1293-1310. doi: 10.3324/haematol.2021.278796.

6. Averna M, Melotti P, Sorio C. Revisiting the Role of Leukocytes in Cystic Fibrosis. Cells. 2021 Dec 1;10(12): 3380. doi: 10.3390/cells10123380.

7. Saluzzo F, Riberi L, Messore B, Loré NI, Esposito I, Bignamini E, De Rose V. CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis. Cells. 2022 Apr 6;11(7):1243. doi: 10.3390/cells11071243.

8. Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022 Jun 9;7(1):182. doi: 10.1038/s41392-022-01036-5.

9. Yan Z, Wang G, Shi X. Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease. Front Pharmacol. 2021 Dec 21;12:785375. doi: 10.3389/fphar.2021.785375.

10. Kongtasai T, Paepe D, Meyer E, Mortier F, Marynissen S, Stammeleer L, Defauw P, Daminet S. Renal biomarkers in cats: A review of the current status in chronic kidney disease. J Vet Intern Med. 2022 Mar;36(2):379-396. doi: 10.1111/jvim.16377.

11. Lousa I, Reis F, Santos-Silva A, Belo L. The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD.Int J Mol Sci. 2022 Mar 18;23(6):3284. doi: 10.3390/ijms23063284.

12. Manuel SS, Luis GM. Nutrition, Obesity and Asthma Inception in Children. The Role of Lung Function. Nutrients. 2021 Oct 28;13(11):3837. doi: 10.3390/nu13113837.

13. Meeks KAC, Bentley AR, Gouveia MH, Chen G, Zhou J, Lei L, Adeyemo AA, Doumatey AP, Rotimi CN. Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits. Genome Med. 2021 Oct 7;13(1):156. doi: 10.1186/s13073-021-00971-2.

14. Cena H, Fiechtner L, Vincenti A, Magenes VC, De Giuseppe R, Manuelli M, Zuccotti GV, Calcaterra V. COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review. Nutrients. 2021 Nov 26;13(12):4255. doi: 10.3390/nu13124255.

15. Herath M, Cohen A, Ebeling PR, Milat F. Dilemmas in the Management of Osteoporosis in Younger Adults. JBMR Plus. 2022 Jan 19;6(1): e10594. doi: 10.1002/jbm4.10594.

16. Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R, McCloskey E, Moss K, Parker J, Paskins Z, Poole K, Reid DM, Stone M, Thomson J, Vine N, Compston J. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2022 Apr 5;17(1):58. doi: 10.1007/s11657-022-01061-5.

17. Maurer DJ, Liu C, Xepapadaki P, Stanic B, Bachert C, Finotto S, Gao YD, Graser A, Jartti T, Kistler W, Kowalski M, Lukkarinen H, Pasioti M, Tan G, Villiger M, Zhang L, Zhang N, Akdis M, Papadopoulos NG, Akdis CA. Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers. Allergy. 2022 Apr;77(4):1216-1230. doi: 10.1111/all.15105.

18. Liu L, Gao Y, Si Y, Liu B, Liu X, Li G, Wang R. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation. J Clin Lab Anal. 2022 May;36(5): e24379. doi: 10.1002/jcla.24379.

19. Liew KY, Koh SK, Hooi SL, Ng MKL, Chee HY, Harith HH, Israf DA, Tham CL. Rhinovirus-Induced Cytokine Alterations With Potential Implications in Asthma Exacerbations: A Systematic Review and Meta-Analysis. Front Immunol. 2022 Feb 15;13:782936. doi: 10.3389/fimmu.2022.782936.

20. Hypponen, E.; Laara, E.; Reunanen, A.; Jarvelin, M.R.; Virtanen, S. M.Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet. 2001, 358, 1500-1503.

21. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia. 1999, 42, 51-54.

22. Gabbay, M.A.L.; Sato, M.N.; Finazzo, C.; Duarte, A.J.S.; Dib, S. A. Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus. Arch. Pediatr. Adolesc. Med. 2012, 166, 601-607.

23. Gregori, S.; Giarratana, N.; Smiroldo, S.; Uskokovic, M.; Adorini, L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002, 51, 1367-1374.

24. Lee, S.; Clark, S.A.; Gill, R.K.; Christakos, S. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: Vitamin D receptors, gene expression, and insulin secretion. Endocrinology. 1994, 134, 1602-1610.

25. Treiber, G.; Prietl, B.; Frohlich-Reiterer, E.; Lechner, E.; Ribitsch, A.; Fritsch, M.; Rami-Merhar, B.; Steigleder-Schweiger, C.; Graninger, W.; Borkenstein, M.; et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus-A randomized clinical trial. Clin. Immunol. 2015, 161, 217-224.

26. Gregoriou, E.; Mamais, I.; Tzanetakou, I.; Lavranos, G.; Chrysostomou, S. The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. Rev. Diabetes Stud. 2017, 14, 260-268.

27. Munger, K.L.; Levin, L.I.; Hollis, B.W.; Howard, N.S.; Ascherio, A. Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA. 2006, 296, 2832-2838.

28. Munger, K.L.; Zhang, S.M.; O’Reilly, E.; Hernan, M.A.; Olek, M.J.; Willett, W.C.; Ascherio, A. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004, 62, 60-65.

29. Floreani A, Leung PS, Gershwin ME. Environmental Basis of Autoimmunity. Clin Rev Allergy Immunol. 2016 Jun; 50(3):287-300.

30. Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2016; 7():697.

31. Duan S, Lv Z, Fan X, Wang L, Han F, Wang H, Bi S. Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis. Neurosci Lett. 2014 Jun 6; 570():108-13.

32. Yue, B.; Luo, X.; Yu, Z.; Mani, S.; Wang, Z.; Dou, W. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System. Microorganisms. 2019, 7, 440.

33. Matricon, J.; Barnich, N.; Ardid, D. Immunopathogenesis of inflammatory bowel disease. Self Nonself. 2010, 1, 299-309.

34. Nemeth, Z.H.; Bogdanovski, D.A.; Barratt-Stopper, P.; Paglinco, S.R.; Antonioli, L.; Rolandelli, R. H. Crohn’s Disease and Ulcerative Colitis Show Unique Cytokine Profiles. Cureus. 2017, 9, e1177.

35. Gálvez, J. Role of Th17 Cells in the Pathogenesis of Human IBD. ISRN Inflamm. 2014, 2014, 928461.

36. Gubatan, J.; Moss, A. C. Vitamin D in inflammatory bowel disease: More than just a supplement. Curr. Opin. Gastroenterol. 2018, 34, 217-225.

37. Fletcher, J.; Cooper, S.C.; Ghosh, S.; Hewison, M. The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients. 2019, 11, 1019.

38. Li, J.; Chen, N.; Wang, D.; Zhang, J.; Gong, X. Efficacy of vitamin D in treatment of inflammatory bowel disease: A meta-analysis. Medicine 2018, 97, e12662.

39. Schäffler, H.; Herlemann, D.P.R.; Klinitzke, P.; Berlin, P.; Kreikemeyer, B.; Jaster, R.; Lamprecht, G. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn’s disease patients, but not in healthy controls. J. Dig. Dis. 2018, 19, 225-234.

40. Höbaus J, Thiem U, Hummel DM, Kallay E. Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem. 2013 Jan; 13(1):20-35.

41. Guo Z, Wen J, Kan Q, Huang S, Liu X, Sun N, Li Z. Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects. Tumor Biology. 2013; 34(5): 3189-3200.

42. Bendardaf R, Saheb Sharif-Askari F, Saheb Sharif-Askari N, Yousuf Guraya S, A AlMadhi S, Abusnana S. Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center.Int J Womens Health. 2020 Oct 27;12:893-899. doi: 10.2147/IJWH.S266335.

43. Narvaez CJ, Matthews D, LaPorta E, Simmons KM, Beaudin S, Welsh J. The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Front Physiol. 2014; 5():213.

44. Ditsch N, Toth B, Mayr D, Lenhard M, Gallwas J, Weissenbacher T, Dannecker C, Friese K, Jeschke U. The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J Histochem Cytochem. 2012 Feb; 60(2):121-9.

45. Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol. 2011 Jun 10; 29(17):2378-85.

46. Santagata S, Thakkar A, Ergonul A, Wang B, Woo T, Hu R, Harrell JC, McNamara G, Schwede M, Culhane AC, Kindelberger D, Rodig S, Richardson A, Schnitt SJ, Tamimi RM, Ince TA. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Invest. 2014 Feb; 124(2):859-70.

47. Zhai N, Bidares R, Makoui MH, Aslani S, Mohammadi P, Razi B, Imani D, Yazdchi M, Mikaeili H. Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: a meta-regression and updated meta-analysis. BMC Endocr Disord. 2020 Aug 8;20(1):121. doi: 10.1186/s12902-020-00575-8.

48. Ataie-Jafari, A.; Loke, S.C.; Rahmat, A.B.; Larijani, B.; Abbasi, F.; Leow, M.K.; Yassin, Z. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes. Clin. Nutr. 2013, 32, 911-917.

49. Lin J, Liu J, Davies ML, Chen W. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis. PLoS One. 2016; 11(1): e0146351.

50. Merlino, L.A.; Curtis, J.; Mikuls, T.R.; Cerhan, J.R.; Criswell, L.A.; Saag, K. G. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis Rheum. 2004, 50, 72-77.

51. Lee, Y.H.; Bae, S. C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: A meta-analysis. Clin. Exp. Rheumatol. 2016, 34, 827-833.

52. Kostoglou-Athanassiou, I.; Athanassiou, P.; Lyraki, A.; Raftakis, I.; Antoniadis, C. Vitamin D and rheumatoid arthritis. Ther. Adv. Endocrinol. Metab. 2012, 3, 181-187.

53. Meena, N.; Singh Chawla, S.P.; Garg, R.; Batta, A.; Kaur, S. Assessment of Vitamin D in Rheumatoid Arthritis and Its Correlation with Disease Activity. J. Nat. Sci. Biol. Med. 2018, 9, 54-58.

54. Aslam, M.M.; John, P.; Bhatti, A.; Jahangir, S.; Kamboh, M. I. Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response. Biomed. Res.Int. 2019, 2019, 3494937.

55. Guo, Q.; Wang, Y.; Xu, D.; Nossent, J.; Pavlos, N.J.; Xu, J. Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018, 6, 15.

56. Kosmaczewska, A.; Swierkot, J.; Ciszak, L.; Wiland, P. The role of Th1, Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines. Postepy Hig. Med. Dosw. 2011, 65, 397-403.

57. Li, S.; Yin, H.; Zhang, K.; Wang, T.; Yang, Y.; Liu, X.; Chang, X.; Zhang, M.; Yan, X.; Ren, Y.; et al. Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity. Sci. Rep. 2017, 7, 4776.

58. Gopinath, K.; Danda, D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: A randomised controlled trial.Int. J. Rheum. Dis. 2011, 14, 332-339.

59. Lee Y.H., Bae S.-C., Choi S. J., Ji J. D., Song G. G. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis. Mol. Biol. Rep. 2011;38:3643-3651. doi: 10.1007/s11033-010-0477-4.

60. Sakthiswary R, Raymond AA. The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review. PLoS One. 2013; 8(1): e55275.

61. Shoenfeld Y, Giacomelli R, Azrielant S, Berardicurti O, Reynolds JA, Bruce IN. Vitamin D and systemic lupus erythematosus - The hype and the hope. Autoimmun Rev. 2018 Jan; 17(1):19-23.

62. Mosaad Y.M., Hammad E. M., Fawzy Z., Abdal Aal I. A., Youssef H. M., ElSaid T.O., Monir R., El-Deek B. S. Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum. Immunol. 2014;75:452-461. doi: 10.1016/j.humimm.2014.02.009.

63. Di Spigna G., Del Puente A., Covelli B., Abete E., Varriale E., Salzano S., Postiglione L. Vitamin D receptor polymorphisms as tool for early screening of severe bone loss in women patients with rheumatoid arthritis. Eur. Rev. Med. Pharmacol. Sci. 2016;20:4664-4669.

64. Karray E.F., Ben Dhifallah I., Ben Abdelghani K., Ben Ghorbel I., Khanfir M., Houman H., Hamzaoui K., Zakraoui L. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet’s disease in Tunisians. Jt. Bone Spine. 2012;79:144-148. doi: 10.1016/j.jbspin.2011.06.003.

65. Song G.G., Bae S.-C., Lee Y. H. Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis: A meta-analysis. Z. Rheumatol. 2016;75:322-329. doi: 10.1007/s00393-015-1581-6.

66. Maalej A., Petit-Teixeira E., Michou L., Rebai A., Cornelis F., Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun. 2005;6:707-711. doi: 10.1038/sj.gene.6364260.

67. Saad M.N., Mabrouk M. S., Eldeib A. M., Shaker O. G. Genetic Case-Control Study for Eight Polymorphisms Associated with Rheumatoid Arthritis. PLoS ONE. 2015;10: e0131960. doi: 10.1371/journal.pone.0131960

68. Al Haj-Mahmoud S.A., Fayiz-Atoum M., Al-Houran H.M., Bateineh S., Abderrahman S., Alzoughool F. Vitamin d deficiency and rs731236 (Taq1) vitamin D receptor gene polymorphism as possible risk factors for rheumatoid arthritis and osteoarthritis. Acta Med. Mediterr. 2018;34:209-213.

69. Garcia-Lozano J.R., Gonzalez-Escribano M.F., Valenzuela A., Garcia A., Núñez-Roldán A. Association Blackwell Science, Ltd of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 2001;28:89-93.

70. Bernardes M., Machado J. C., Gonçalves D. et al. AB0272 Bsmi and Foki VDR Gene Polymorphisms Influence Disease Activity in Established Rheumatoid Arthritis Patients. Ann. Rheum. Dis. 2014;73(Suppl. 2):894. doi: 10.1136/annrheumdis-2014-eular.3913.

71. Kaviani N., Yazdani Y., Hadi B. The Association of Vitamin D Receptor Polymorphisms of FokI and TaqI with Rheumatoid Arthritis in North-East of Iran. Jorjani Biomed. J. 2019;7:20-29. doi: 10.29252/jorjanibiomedj.7.4.20.

72. Bagheri-Hosseinabadi Z, Imani D, Yousefi H, Abbasifard M. Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis. Clin Rheumatol. 2020 Dec;39(12):3555-3569. doi: 10.1007/s10067-020-05143-y.

73. Ahmed A.E., Sakhr H. M., Hassan M. H., El-Amir M.I., Ameen H. H. Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy. Diabetes Metab Syndr Obes. 2019 May 14;12:703-716. doi: 10.2147/DMSO.S201525.

74. Dorjgochoo T, Shi J, Gao YT, Long J, Delahanty R, Xiang YB, Cai Q, Shu XO. Genetic variants in vitamin D metabolism-related genes and body mass index: analysis of genome-wide scan data of approximately 7000 Chinese women.Int J Obes (Lond). 2012 Sep; 36(9):1252-5.

75. Vimaleswaran KS, Cavadino A, Berry DJ, Genetic Investigation of Anthropometric Traits (GIANT) Consortium., Whittaker JC, Power C, Järvelin MR, Hyppönen E. Genetic association analysis of vitamin D pathway with obesity traits.Int J Obes (Lond). 2013 Oct; 37(10):1399-406.

76. Ruiz-Ojeda FJ, Anguita-Ruiz A, Leis R, Aguilera CM. Genetic Factors and Molecular Mechanisms of Vitamin D and Obesity Relationship. Ann Nutr Metab. 2018; 73(2):89-99.

77. Al-Daghri NM, Al-Attas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, Ansari MG, Alenad A, Alokail MS. Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency. Gene. 2014 Jun 1; 542(2):129-33.

78. Al-Hazmi AS, Al-Mehmadi MM, Al-Bogami SM, Shami AA, Al-Askary AA, Alomery AM, Al-Shehri SS, Dahlawi H, Abdulrazag K, Ali T, Al-Bogami A, Sheshah E, Al-Mutairi A, Al-Suhimi S, Alharb F Vitamin D receptor gene polymorphisms as a risk factor for obesity in Saudi men. Electron Physician. 2017 Oct; 9(10):5427-5433.

79. Ferrarezi DA, Bellili-Munoz N, Nicolau C, Cheurfa N, Guazzelli IC, Frazzatto E, Velho G, Villares S. M. Allelic variations in the vitamin D receptor gene, insulin secretion and parents’ heights are independently associated with height in obese children and adolescents. Metabolism. 2012;61:1413-21.

80. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medras M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134-9.

81. Hasan HA, AbuOdeh RO, Muda WAMBW, Mohamed HJBJ, Samsudin AR. Association of Vitamin D receptor gene polymorphisms with metabolic syndrome and its components among adult Arabs from the United Arab Emirates. Diabetes Metab Syndr. 2017 Dec; 11 Suppl 2(): S531-S537.

82. Malik R, Farooq R, Mehta P, Ishaq S, Din I, Shah P, Majid S. Association of Vitamin D Receptor Gene Polymorphism in Adults With Type 2 Diabetes in the Kashmir Valley. Can J Diabetes. 2018;42:251-6

83. Safar HA, Chehadeh SEH, Abdel-Wareth L, Haq A, Jelinek HF, ElGhazali G, Anouti FA. Vitamin D receptor gene polymorphisms among Emirati patients with type 2 diabetes mellitus. J Steroid Biochem Mol Biol. 2018;175:119-24.

84. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002;51:356-9.

85. Zhang H, Wang J, Yi B, Zhao Y, Liu Y, Zhang K, Cai X, Sun J, Huang L, Liao Q. BsmI polymorphisms in vitamin D receptor gene are associated with diabetic nephropathy in type 2 diabetes in the Han Chinese population. Gene. 2012 Mar 10; 495(2):183-8.

86. Zostautiene I, Jorde R, Schirmer H, Mathiesen EB, Njølstad I, Løchen ML, Wilsgaard T, Joakimsen RM, Kamycheva E. Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study. PLoS One. 2015; 10(12): e0145359.

87. Mukhopadhyaya PN, Acharya A, Chavan Y, Purohit SS, Mutha A. Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res. 2010;9:2060-8.

88. Bienertova-Vasku J, Zlamal F, Pohorala A, Mikes O, Goldbergova-Pavkova M, Novak J, Splichal Z, Pikhart H. Allelic variants in vitamin D receptor gene are associated with adiposity measures in the central-European population. BMC Med Genet. 2017;18:90.

89. Binh TQ, Nakahori Y, Hien VT, Khan NC, Lam NT, Mai le B, Yamamoto S Correlations between genetic variance and adiposity measures, and gene x gene interactions for obesity in postmenopausal Vietnamese women. J Genet. 2011;90:1-9.

90. Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade BW, Hales CN, Boucher BJ. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes. 1998;47:688-90.

91. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci. 2004;59:10-5.

92. Angel B, Lera L, Márquez C, Albala C. The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile. Nutr Diabetes. 2018 May 25; 8(1):31.

93. Yu F, Cui LL, Li X, Wang CJ, Ba Y, Wang L, Li J, Li C, Dai LP, Li WJ. The genetic polymorphisms in vitamin D receptor and the risk of type 2 diabetes mellitus: an updated meta-analysis. Asia Pac J Clin Nutr. 2016; 25(3): 614-24.

94. Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12(7):2097. https://doi.org/10.3390/nu12072097

95. McNally JD, Nama N, O’Hearn K, Sampson M, Amrein K, Iliriani K, McIntyre L, Fergusson D, Menon K. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Crit Care. 2017 Nov 23;21(1):287. doi: 10.1186/s13054-017-1875-y.

96. Awasthi N, Awasthi S, Pandey S. Role of VDR gene polymorphisms with community acquired pneumonia in North Indian children: a case-control study.Int J Mol Epidemiol Genet. 2021 Feb 15;12(1):1-8.

97. White J. H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol. 2010;121:234-238.

98. Marshall B, Bennett N, Smith A, Oh R, Burket J. PURL: Can vitamin D prevent acute respiratory infections? J Fam Pract. 2019 May;68(4):230-231.

99. Jolliffe DA, Camargo CA Jr, Sluyter J. D. et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30. PMID: 33798465.

100. Zemb P, Bergman P, Camargo CA Jr. et al. Vitamin D deficiency and the COVID-19 pandemic. J Glob Antimicrob Resist. 2020 Sep;22:133-134. doi: 10.1016/j.jgar.2020.05.006.

101. Sassi F., Tamone C., D’Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018;10:1656.

102. Tangpricha V, Lukemire J, Chen Y. et al. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial. Am J Clin Nutr. 2019 Mar 1;109(3):544-553. doi: 10.1093/ajcn/nqy291.

103. Olszowiec-Chlebna, M., Koniarek-Maniecka, A., Brzozowska, A. et al. Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study. Ital J Pediatr. 2019;45: 41. doi: 10.1186/s13052-019-0634-x.

104. Jiang N, Zhao XQ, Qin CH, Hu YJ, Wang L, Xie GP, Wang SN, Chen LG, Yu B. Association of vitamin D receptor gene TaqI, BsmI, FokI and ApaI polymorphisms and susceptibility to extremity chronic osteomyelitis in Chinese population. Injury. 2016 Aug;47(8):1655-60. doi: 10.1016/j.injury.2016.06.005.

105. Xie X, Li J, Gu F, Zhang K, Su Z, Wen Q, Sui Z, Zhou P, Yu T. Genetic Determinants for Bacterial Osteomyelitis: A Focused Systematic Review of Published Literature. Front Genet. 2021 Jun 17;12:654792. doi: 10.3389/fgene.2021.654792.

106. Floyd, K., Glaziou P., Zumla A., Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: An overview in year 3 of the End TB era. Lancet Respir. Med. 2018; 6: 299-314.

107. Sasindran S.J., Torrelles J. B. Mycobacterium Tuberculosis Infection and Inflammation: What is Beneficial for the Host and for the Bacterium? Front. Microbiol. 2011; 2: 2.

108. Aibana O., Huang, C.C., Aboud S. et al. Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Med. 2019; 16: e1002907.

109. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis.Int. J. Epidemiol. 2008; 37: 113-119.

110. Hossein-nezhad, A.; Spira, A.; Holick, M. F. Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial. PLoS ONE. 2013; 8: e58725.

111. Naik, A.L.; Rajan, M.G.; Manjrekar, P.A.; Shenoy, M.T.; Shreelata, S.; Srikantiah, R.M.; Hegde, A. Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis. J. Clin. Diagn. Res. 2017; 11: BC18-BC22.

112. Nursyam, E.W.; Amin, Z.; Rumende, C. M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones. 2006; 38: 3-5.

113. Mily, A.; Rekha, R.S.; Kamal, S.M.; Arifuzzaman, A.S.; Rahim, Z.; Khan, L.; Haq, M.A.; Zaman, K.; Bergman, P.; Brighenti, S.; et al. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial. PLoS ONE. 2015; 10: e0138340.

114. Martineau, A.R.; Timms, P.M.; Bothamley, G.H.; Hanifa, Y.; Islam, K.; Claxton, A.P.; Packe, G.E.; Moore-Gillon, J.C.; Darmalingam, M.; Davidson, R.N.; et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet. 2011; 377: 242-250.

115. Salahuddin, N.; Ali, F.; Hasan, Z.; Rao, N.; Aqeel, M.; Mahmood, F. Vitamin D accelerates clinical recovery from tuberculosis: Results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect. Dis. 2013; 13: 22.

116. Daley, P.; Jagannathan, V.; John, K.R.; Sarojini, J.; Latha, A.; Vieth, R.; Suzana, S.; Jeyaseelan, L.; Christopher, D.J.; Smieja, M.; et al. Adjunctive vitamin D for treatment of active tuberculosis in India: A randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 2015; 15: 528-534.

117. Tukvadze, N.; Sanikidze, E.; Kipiani, M.; Hebbar, G.; Easley, K.A.; Shenvi, N.; Kempker, R.R.; Frediani, J.K.; Mirtskhulava, V.; Alvarez, J.A.; et al. High-dose vitamin D3 in adults with pulmonary tuberculosis: A double-blind randomized controlled trial. Am. J. Clin. Nutr. 2015; 102: 1059-1069.

118. Ganmaa, D.; Munkhzul, B.; Fawzi, W.; Spiegelman, D.; Willett, W.C.; Bayasgalan, P.; Baasansuren, E.; Buyankhishig, B.; Oyun-Erdene, S.; Jolliffe, D.A.; et al. High-Dose Vitamin D(3) during Tuberculosis Treatment in Mongolia. A Randomized Controlled Trial. Am. J. Respir. Crit. Care Med. 2017; 196: 628-637.

119. Sherkatolabbasieh H, Firouzi M, Shafizadeh S, Nekohid M. Evaluation of the relationship between vitamin D levels and prevalence of urinary tract infections in children. New Microbes New Infect. 2020 Jul 7;37:100728. doi: 10.1016/j.nmni.2020.100728.

120. Deng Qi-Fei, Han Chu, Zhu Wen, Cao Yong-Sheng. Vitamin D and urinary tract infection: a systematic review and meta-analysis. Ann Clin Lab Sci. 2019;49:134-142.

121. Yang Jianhuan, Chen Guangdao, Wang Dexuan, Chen Minguang, Xing Chao, Wang Bin. Low serum 25-hydroxyvitamin D level and risk of urinary tract infection in infants. Medicine (Baltimore). 2016;95: e4137.

122. Rello, J.; Valenzuela-Sánchez, F.; Ruiz-Rodriguez, M.; Moyano, S. Sepsis: A Review of Advances in Management. Adv. Ther. 2017; 34: 2393-2411.

123. de Haan, K.; Groeneveld, A.B.J.; de Geus, H.R.H.; Egal, M.; Struijs, A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: Systematic review and meta-analysis. Crit. Care. 2014; 18: 660.

124. Vipul, P.; Shuchi, C.; Avinash, A.; Manish, G.; Sukriti, K.; Ved, P. Correlation of Serum Vitamin D Level with Mortality in Patients with Sepsis. Indian J. Crit. Care Med. 2017; 21: 199-204.

125. Kempker, J.A.; Han, J.E.; Tangpricha, V.; Ziegler, T.R.; Martin, G. S. Vitamin D and sepsis: An emerging relationship. Dermatol. Endocrinol. 2012; 4: 101-108.

126. Gibson, C.C.; Davis, C.T.; Zhu, W.; Bowman-Kirigin, J.A.; Walker, A.E.; Tai, Z.; Thomas, K.R.; Donato, A.J.; Lesniewski, L.A.; Li, D. Y. Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium. PLoS ONE. 2015;10: e0140370.

127. Rübsamen, D.; Kunze, M.M.; Buderus, V.; Brauß, T.F.; Bajer, M.M.; Brüne, B.; Schmid, T. Inflammatory conditions induce IRES-dependent translation of cyp24a1. PLoS ONE. 2014; 9: e85314.

128. Dahl, B.; Schiodt, F.V.; Ott, P.; Wians, F.; Lee, W.M.; Balko, J.; O’Keefe, G. E. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit. Care Med. 2003; 31: 152-156.

129. Kew, R. R. The Vitamin D Binding Protein and Inflammatory Injury: A Mediator or Sentinel of Tissue Damage? Front. Endocrinol. (Lausanne). 2019; 10: 470.

130. Quraishi, S.A.; De Pascale, G.; Needleman, J.S.; Nakazawa, H.; Kaneki, M.; Bajwa, E.K.; Camargo, C.A., Jr.; Bhan, I. Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit. Care Med. 2015; 43: 1928-1937.

131. Leaf, D.E.; Raed, A.; Donnino, M.W.; Ginde, A.A.; Waikar, S. S. Randomized controlled trial of calcitriol in severe sepsis. Am. J. Respir. Crit. Care Med. 2014; 190: 533-541.

132. Amrein, K.; Schnedl, C.; Holl, A.; Riedl, R.; Christopher, K.B.; Pachler, C.; Urbanic Purkart, T.; Waltensdorfer, A.; Munch, A.; Warnkross, H.; et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: The VITdAL-ICU randomized clinical trial. JAMA. 2014; 312: 1520-1530.

133. Martucci, G.; McNally, D.; Parekh, D.; Zajic, P.; Tuzzolino, F.; Arcadipane, A.; Christopher, K.B.; Dobnig, H.; Amrein, K. Trying to identify who may benefit most from future vitamin D intervention trials: A post hoc analysis from the VITDAL-ICU study excluding the early deaths. Crit. Care. 2019; 23: 200.

134. Han, J.E.; Jones, J.L.; Tangpricha, V.; Brown, M.A.; Brown, L.A.S.; Hao, L.; Hebbar, G.; Lee, M.J.; Liu, S.; Ziegler, T.R.; et al. High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial. J. Clin. Transl. Endocrinol. 2016; 4: 59-65.

135. National Heart, L.; Blood Institute, P.C.T.N.; Ginde, A.A.; Brower, R.G.; Caterino, J.M.; Finck, L.; Banner-Goodspeed, V.M.; Grissom, C.K.; Hayden, D.; Hough, C.L.; et al. Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. N. Engl. J. Med. 2019; 381: 2529-2540.

136. Cannell, J.J.; Vieth, R.; Umhau, J.C.; Holick, M.F.; Grant, W.B.; Madronich, S.; Garland, C.F.; Giovannucci, E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006; 134: 1129-1140.

137. Gunville, C.F.; Mourani, P.M.; Ginde, A. A. The role of vitamin D in prevention and treatment of infection. Inflamm. Allergy Drug Targets. 2013; 12: 239-245.

138. Ingham, T.R.; Jones, B.; Camargo, C.A.; Kirman, J.; Dowell, A.C.; Crane, J.; Stanley, T.V.; Grimwood, K.; The Whiti Te Ra Study, G. Association of vitamin D deficiency with severity of acute respiratory infection: A case-control study in New Zealand children. Eur. Respir. J. 2014; 44: 439.

139. Sabetta, J.R.; DePetrillo, P.; Cipriani, R.J.; Smardin, J.; Burns, L.A.; Landry, M. L. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE. 2010; 5: e11088.

140. Beard, J.A.; Bearden, A.; Striker, R. Vitamin D and the anti-viral state. J. Clin. Virol. 2011; 50: 194-200.

141. Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; et al. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 2017; 356: i6583.

142. Fouad, M.N.; Ruffin, J.; Vickers, S.M. COVID-19 is Out of Proportion in African Americans. This Will Come as No Surprise. Am. J. Med. 2020: 30411-30413.

143. Dietz, W.; Santos-Burgoa, C. Obesity and its Implications for COVID-19 Mortality. Obesity. 2020; 28: 1005.

144. Cui, C.; Xu, P.; Li, G.; Qiao, Y.; Han, W.; Geng, C.; Liao, D.; Yang, M.; Chen, D.; Jiang, P. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019; 26: 101295.

145. Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Aliano, J.L.; Bhattoa, H. P. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020; 12: 988.

146. Mendy, A.; Apewokin, S.; Wells, A.A.; Morrow, A. L. Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients. medRxiv. 2020.

147. Hossein-nezhad, A.; Holick, M. F. Vitamin D for Health: A Global Perspective. Mayo Clin. Proc. 2013; 88: 720-755.

148. Roth DE, Soto G, Arenas F, Bautista CT, Ortiz J, Rodriguez R, Cabrera L, Gilman RH. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis. 2004 Sep 1;190(5):920-7. doi: 10.1086/423212.

149. Zhang J, Chen C, Yang J. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials. Chin Med J (Engl). 2019 Dec 20;132(24):2950-2959. doi: 10.1097/CM9.0000000000000554.

150. Wu HX, Xiong XF, Zhu M, Wei J, Zhuo KQ, Cheng DY. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. 2018 Jun 28; 18(1):108. doi: 10.1186/s12890-018-0677-6.